from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3688c/-

LFCtreatmentdescriptionclass of inhibitor

-0.149

Amikacinug/mL Amikacintranslation

0.282

Cap5-10ug/mL Capreomycintranslation

-0.494

Rox10-50 ug/mL Roxithromycintranslation

-0.588

SM2-5 ug/mL Streptomycintranslation

0.127

Tet5-10 ug/mL Tetracyclinetranslation

0.112

Rif0.2-5ug/mL Rifampicintranscription

0.155

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.002

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.396

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.219

CPZ10-50 ug/mL Chlorpromazinerespiration

0.456

Clofazimine10-13 ug/mL Clofaziminerespiration

0.638

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.403

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.102

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.892

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.031

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.019

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.540

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.622

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.611

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.683

KCN5-20 ug/mL Potassium cyaniderespiration

0.549

NaN30.2-2 mM Sodium aziderespiration

0.221

Nigericin50 uM Nigericinrespiration

-0.201

TRC10-150 ug/mL Triclosanrespiration

1.150

TRZ10-25 ug/mL Thioridazinerespiration

-1.301

Valinomycin0.5-10 uM Valinomycinrespiration

-0.359

ZnSO42 mM ZnSO4respiration

0.291

menadione6-10 ug/mL Menadionerespiration

0.624

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.310

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.393

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.014

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.303

NRP_1Non-replicating persistence stage 1dosRassociated

-0.752

Amp0.2mg/mL AmpicillincellWall

0.042

Cephalexin20-100 ug/mL CephalexincellWall

0.202

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.471

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.057

EMB10-20 ug/mL EthambutolcellWall

0.066

Eta12-40 ug/mL EthionamidecellWall

0.154

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.233

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.723

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.888

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.670

BZA0.12 mg/mL BenzamidearomaticAmides

-0.443

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.265

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.351

H2O24 mM hydrogen peroxideDNAdamaging

0.158

Levo10 ug/mL LevofloxacinDNAdamaging

-1.162

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.238

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.762

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.230

UVUV-irradiationDNAdamaging

1.507

ARP41-4 ug/mL Antitubercular compound ARP4?

0.673

Antimycin12.5-50 ug/mL Antimycin A?

0.561

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.485

PA_110-50 ug/mL Antitubercular compound PA-1?

0.297

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.233

PA8240.2-2 ug/mL PA-824?

-0.027

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.514

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.938

Verapamil50 uM Verapamil?

1.016

mercaptoethanol2 mM 2-Mercaptoethanol?

0.403

methoxatin10-20 ug/mL Methoxatin?